Efficacy of pramipexole treatment and methylphenidate in children with attention deficit hyperactivity disorder, compared with placebo and methylphenidate.
Phase 2
- Conditions
- attention deficit hyperactivity disorder.Disturbance of activity and attention
- Registration Number
- IRCT201612253979N6
- Lead Sponsor
- Research Devision, Ahvaz Jondishapoor Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Children 6-12 years old;Having diagnostic criteria and testing Connors.
Exclusion criteria: medical conditions such as kidney failure and epilepsy;psychiatric disorders with a focus on DSM IV-TR; mental disability;history of seizures other than seizures associated with fever,need for dopaminergic drugs, levodopa, ranitidine, cimetidine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attention Deficit Hyperactivity Disorder. Timepoint: Befor intervention- the end of second, fourth and sixth weeks of the study. Method of measurement: The Conner's parent rating scale.
- Secondary Outcome Measures
Name Time Method